Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -43.61%4.82M | -44.40%5.3M | -44.40%5.3M | -44.27%5.72M | -36.89%7.12M | -28.48%8.54M | -22.43%9.53M | -22.43%9.53M | -21.37%10.26M | -19.39%11.28M |
-Cash and cash equivalents | -67.56%614.89K | -57.92%381.9K | -57.92%381.9K | -82.44%555.71K | -26.54%1.21M | -51.12%1.9M | 43.91%907.55K | 43.91%907.55K | 654.28%3.16M | 12.82%1.64M |
-Short-term investments | -36.77%4.2M | -42.98%4.91M | -42.98%4.91M | -27.26%5.17M | -38.66%5.91M | -17.59%6.64M | -26.02%8.62M | -26.02%8.62M | -43.80%7.1M | -23.14%9.63M |
Receivables | -26.96%5.53K | -53.20%16.07K | -53.20%16.07K | -54.73%13.33K | -54.40%10.45K | -42.04%7.57K | -0.73%34.33K | -0.73%34.33K | 22.72%29.45K | 8.23%22.91K |
-Taxes receivable | -26.96%5.53K | -53.20%16.07K | -53.20%16.07K | -54.73%13.33K | -54.40%10.45K | -42.04%7.57K | -0.73%34.33K | -0.73%34.33K | 22.72%29.45K | 8.23%22.91K |
Prepaid assets | -16.12%47.87K | -35.42%100.9K | -35.42%100.9K | 117.40%439.64K | -19.61%229.36K | 17.99%57.06K | -11.58%156.23K | -11.58%156.23K | -8.20%202.23K | -13.04%285.33K |
Total current assets | -43.41%4.87M | -44.29%5.41M | -44.29%5.41M | -41.18%6.17M | -36.50%7.36M | -28.31%8.6M | -22.21%9.72M | -22.21%9.72M | -21.07%10.5M | -19.21%11.59M |
Non current assets | ||||||||||
Net PPE | 38.83%4.17M | 79.16%4.09M | 79.16%4.09M | 62.47%3.77M | 127.50%3.3M | 15.82%3M | -3.75%2.28M | -3.75%2.28M | 10.33%2.32M | 6.59%1.45M |
Investments and advances | -5.75%8.38K | 67.12%12.4K | 67.12%12.4K | 14.99%10.25K | 63.71%14.34K | -38.71%8.89K | -54.94%7.42K | -54.94%7.42K | -72.69%8.91K | -89.88%8.76K |
Total non current assets | 38.70%4.18M | 79.12%4.1M | 79.12%4.1M | 62.28%3.78M | 127.12%3.31M | 15.51%3.01M | -4.10%2.29M | -4.10%2.29M | 8.32%2.33M | 0.82%1.46M |
Total assets | -22.11%9.05M | -20.76%9.51M | -20.76%9.51M | -22.38%9.96M | -18.20%10.67M | -20.48%11.62M | -19.31%12.01M | -19.31%12.01M | -16.98%12.83M | -17.37%13.05M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -87.82%78.2K | -71.23%183.72K | -71.23%183.72K | -19.72%97.86K | -32.55%73.62K | 217.23%641.89K | 888.65%638.67K | 888.65%638.67K | --121.9K | --109.13K |
-accounts payable | -87.82%78.2K | -71.23%183.72K | -71.23%183.72K | -19.72%97.86K | -32.55%73.62K | 217.23%641.89K | 888.65%638.67K | 888.65%638.67K | --121.9K | --109.13K |
Current accrued expenses | 85.56%30.89K | 18.58%44.98K | 18.58%44.98K | -1.49%13.33K | --13.15K | 50.20%16.65K | 14.17%37.93K | 14.17%37.93K | --13.54K | --0 |
Current liabilities | -83.43%109.09K | -66.20%228.7K | -66.20%228.7K | -17.90%111.2K | -20.50%86.77K | 208.55%658.54K | 591.65%676.61K | 591.65%676.61K | -57.29%135.43K | -65.07%109.13K |
Non current liabilities | ||||||||||
Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Total liabilities | -83.43%109.09K | -66.20%228.7K | -66.20%228.7K | -17.90%111.2K | -20.50%86.77K | 208.55%658.54K | 591.65%676.61K | 591.65%676.61K | -57.29%135.43K | -65.07%109.13K |
Shareholders'equity | ||||||||||
Share capital | 0.00%16.57M | 0.00%16.57M | 0.00%16.57M | 1.46%16.57M | 1.46%16.57M | 1.46%16.57M | 1.46%16.57M | 1.46%16.57M | 5.16%16.33M | -0.92%16.33M |
-common stock | 0.00%16.57M | 0.00%16.57M | 0.00%16.57M | 1.46%16.57M | 1.46%16.57M | 1.46%16.57M | 1.46%16.57M | 1.46%16.57M | 5.16%16.33M | -0.92%16.33M |
Retained earnings | -35.95%-10.6M | -43.85%-10.1M | -43.85%-10.1M | -76.01%-9.36M | -67.37%-8.41M | -122.40%-7.8M | -132.48%-7.02M | -132.48%-7.02M | -164.36%-5.32M | -90.16%-5.03M |
Gains losses not affecting retained earnings | 35.84%2.97M | 58.07%2.82M | 58.07%2.82M | 57.01%2.64M | 48.69%2.43M | 39.19%2.19M | 21.18%1.78M | 21.18%1.78M | 3.92%1.68M | 19,484.98%1.63M |
Total stockholders'equity | -18.43%8.94M | -18.05%9.28M | -18.05%9.28M | -22.43%9.85M | -18.18%10.58M | -23.88%10.96M | -23.35%11.33M | -23.35%11.33M | -16.13%12.69M | -16.41%12.94M |
Total equity | -18.43%8.94M | -18.05%9.28M | -18.05%9.28M | -22.43%9.85M | -18.18%10.58M | -23.88%10.96M | -23.35%11.33M | -23.35%11.33M | -16.13%12.69M | -16.41%12.94M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |